A
BSX icon

Allianz’s Boston Scientific BSX Stock Holding History

Allianz’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.44M Buy
33,761
+6,911
+26% +$375K 0.02% 274
2026
Q1 		$1.68M Buy
26,850
+8,484
+46% +$679K 0.02% 252
2025
Q4 		$1.75M Buy
18,366
+4,596
+33% +$451K 0.02% 223
2025
Q3 		$1.34M Buy
13,770
+11,000
+397% +$1.14M 0.03% 214
2025
Q2 		$298K Hold
2,770
– – 0.01% 277
2025
Q1 		$279K Hold
2,770
– – 0.01% 296
2024
Q4 		$248K Sell
2,770
-14,683
-84% -$1.29M 0.01% 312
2024
Q3 		$1.46M Buy
17,453
+12,803
+275% +$1.01M 0.04% 197
2024
Q2 		$358K Sell
4,650
-10,686
-70% -$782K 0.01% 293
2024
Q1 		$1.05M Buy
+15,336
New +$986K 0.03% 217

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Allianz's BSX Position: Q2 2026 in Review

Allianz increased its Boston Scientific (BSX) stake by 26% in Q2 2026, buying an estimated $375K and bringing the position to 33,761 shares worth $1.44M. The position accounts for 0.02% of the portfolio, ranked #274.

Allianz first reported a position in BSX in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.75M in Q4 2025. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Allianz held 33,761 shares of Boston Scientific worth $1.44M as of Q2 2026.
  • Allianz bought 6,911 Boston Scientific shares in Q2 2026, an estimated $375K.
  • Boston Scientific made up 0.02% of Allianz's portfolio in Q2 2026, its #274 holding.
  • Allianz first reported a position in Boston Scientific in Q1 2024 and has held it in 10 quarters since.
  • Allianz's Boston Scientific position peaked at $1.75M in Q4 2025.
  • 1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Allianz's 13F filing for Q2 2026, filed 10 Aug 2026.